(Q84549758)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Melissa M Coughlin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

John Babcook

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Bellur S Prabhakar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

12 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

39-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

Coronaviruses: from common colds to severe acute respiratory syndrome

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

A human SARS-CoV neutralizing antibody against epitope on S2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Rates of evolutionary change in viruses: patterns and determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Recent antiviral strategies against human coronavirus-related respiratory illnesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Viral evolution and the emergence of SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Severe acute respiratory syndrome--a new coronavirus from the Chinese dragon's lair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Bats are natural reservoirs of SARS-like coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

The growth and potential of human antiviral monoclonal antibody therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Virology. Researchers tie deadly SARS virus to bats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

New respiratory viruses of humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Structural characterization of the SARS-coronavirus spike S fusion protein core.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

The SARS-CoV S glycoprotein: expression and functional characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.07.028

Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19748648

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SARS virus: the beginning of the unraveling of a new coronavirus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19748648

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2009.07.028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19748648%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference